Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Onderstepoort J Vet Res ; 67(1): 71-4, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10843325

ABSTRACT

One group of BALB/c mice infected with a highly virulent strain of Trypanosoma brucei gambiense were treated intraperitoneally with three series of three injections (each injection of 10 mg/kg) of Mel-B separated by seven days of rest, while a second group was treated once by a single injection All the Mel-B treated mice in both experiments were negative for parasites when examined using either the wet blood film or buffy coat methods, but were intermittently PCR positive during the sampling period. We encourage the use of a repeat negative PCR test over a one month period in combination with corroborative clinical and parasitological investigation to be suggestive of cure in experimental animals previously infected with trypanosomosis. In view of the exorbitant costs of Mel-B and its extreme toxicity, we recommend that Mel-B be given as one course of two injections (each equivalent to 10 mg/kg) separated by 2 d of rest in experimentally infected rodent models.


Subject(s)
Melarsoprol/administration & dosage , Trypanocidal Agents/administration & dosage , Trypanosoma brucei gambiense , Trypanosomiasis, African/drug therapy , Trypanosomiasis, African/veterinary , Animals , Mice , Mice, Inbred BALB C , Trypanosoma brucei gambiense/genetics , Trypanosomiasis, African/diagnosis
2.
Korean J Parasitol ; 37(4): 289-92, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10634047

ABSTRACT

BALB/c mice infected with a high virulent strain of Trypanosoma brucei gambiense IL3707 were treated intraperitoneally (i.p.) with either Melarsoprol (Mel-B) or PSG(+) buffer as controls. The mice were subsequently monitored regularly for parasites by direct microscopic examination of their tail blood or buffy coat and by polymerase chain reaction (PCR). Mel-B was found to be an effective drug for treatment against T.b. gambiense because at the end of the first treatment schedule, all treated mice were negative for parasites even by PCR, while all the control animals were positive. Three of the five Mel-B treated mice, while parasitologically negative, were PCR positive between 53 and 80 days post infection (DPI), indicating that they still harbored an infection. All treated mice were subsequently negative for parasites even by PCR at 88 DPI. A combination of conventional microscopic examination and PCR offers a good prediction of cure following treatment of trypanosomosis.


Subject(s)
Melarsoprol/therapeutic use , Trypanocidal Agents/therapeutic use , Trypanosoma brucei gambiense , Trypanosomiasis, African/drug therapy , Animals , Follow-Up Studies , Mice , Mice, Inbred BALB C , Polymerase Chain Reaction , Trypanosoma brucei gambiense/genetics , Trypanosomiasis, African/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL
...